The two main types are glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists such as tirzepatide (Zepbound)
Only buy 60mg vials if you're dosing 4mg+/week and have experience with the compound
This gradual introduction helps your body adjust to the medication, reducing the likelihood of side effects like nausea or stomach discomfort
This lower concentration makes drawing slightly larger volumes easier and is often preferred for lower mcg protocols, enhancing the precision of the Retatrutide dose planning phase
The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease